[18F]fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies

Ann Neurol. 2000 Jul;48(1):105-8.

Abstract

The diagnosis of cancer is often difficult in patients with paraneoplastic neurological syndrome and anti-Hu antibodies. Fluorodeoxyglucose 18 positron emission tomography scanning is a highly sensitive and specific method to detect lung tumors. We investigated 15 patients with paraneoplastic neurological syndrome and anti-Hu antibodies. Radiological methods led to the diagnosis of cancer in 12 patients, and test results were negative in 3. Whole-body [18F]fluorodeoxyglucose positron emission tomography showed abnormal uptake in the mediastinum in these 3 patients in accordance with the expected location of the malignancy.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • ELAV Proteins
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Lung Neoplasms / diagnostic imaging*
  • Lung Neoplasms / immunology*
  • Male
  • Middle Aged
  • Nerve Tissue Proteins / immunology*
  • Paraneoplastic Syndromes / diagnostic imaging*
  • Paraneoplastic Syndromes / immunology*
  • RNA-Binding Proteins / immunology*
  • Tomography, Emission-Computed

Substances

  • ELAV Proteins
  • Nerve Tissue Proteins
  • RNA-Binding Proteins
  • Fluorodeoxyglucose F18